Rockall Score Calculator — Upper GI Bleeding Mortality Risk Stratification
The Rockall score (also known as the admission Rockall score or full Rockall score) is a validated clinical scoring system used to predict mortality risk in patients presenting with upper gastrointestinal bleeding. It combines clinical parameters (age, shock, comorbidity) with endoscopic findings (diagnosis, stigmata of recent hemorrhage) to stratify patients into low, moderate, high, and very high mortality risk categories.
About
The Rockall score was developed by Rockall et al. in 1996 based on data from the UK national audit of upper gastrointestinal hemorrhage. It consists of three pre-endoscopy clinical variables (age, presence of shock, and comorbidities) and two endoscopic variables (diagnosis and stigmata of recent hemorrhage). The total score ranges from 0 to 11, with higher scores indicating greater mortality risk. The score is widely used in clinical practice to guide triage decisions, determine the urgency of endoscopy, and predict patient outcomes. A score of 0-2 suggests low mortality risk (<3%), 3-4 moderate risk (5-10%), 5-6 high risk (10-20%), and 7-11 very high risk (30-60%).
Formula
Rockall = Age(0-2) + Shock(0-2) + Comorbidity(0-3) + Diagnosis(0-2) + Stigmata(0-2)
The Rockall score is calculated by summing points from five variables. Age: <60 years = 0, 60-79 years = 1, ≥80 years = 2. Shock: No shock (SBP ≥100 mmHg and pulse <100 bpm) = 0, Tachycardia (pulse ≥100 bpm, SBP ≥100 mmHg) = 1, Hypotension (SBP <100 mmHg) = 2. Comorbidity: None = 0, CHF/CAD/renal/liver disease = 2, Renal failure/liver disease/metastatic cancer = 3. Endoscopic diagnosis: Mallory-Weiss tear or no lesion identified = 0, All other diagnoses = 1, Upper GI malignancy = 2. Stigmata of recent hemorrhage: None or spot only = 0, Blood in lumen/adherent clot/visible vessel = 1. Total score ranges from 0-11. The score stratifies patients into four mortality risk groups: Low (0-2, <3% mortality), Moderate (3-4, 5-10%), High (5-6, 10-20%), Very High (7-11, 30-60%). Note: The "clinical" or "admission" Rockall score uses only the first three variables (age, shock, comorbidity) without endoscopic findings, while the "full" Rockall score includes all five variables.
Score Interpretation
The Rockall score is a well-validated tool for predicting mortality in upper GI bleeding, one of the most common gastroenterological emergencies with an estimated annual incidence of 50-150 per 100,000 population. The score aids in clinical decision-making by identifying patients who may benefit from early discharge (Rockall 0-2) versus those requiring intensive monitoring and urgent endoscopic intervention (Rockall ≥5). The score has been externally validated in multiple populations and healthcare settings. Key strengths include its simplicity, use of routinely available clinical and endoscopic data, and clear mortality risk stratification. Limitations include reduced discriminative performance in certain subgroups (e.g., variceal bleeding) and the requirement for endoscopic findings for the full score. The clinical or admission Rockall score (using only age, shock, and comorbidity) can be calculated immediately upon presentation without endoscopic data.
Low Mortality Risk — 0–2
Rockall Score 0-2. Low mortality risk (<3%).
Management: Low-risk patient. May be suitable for early discharge. Consider oral PPI therapy. Outpatient follow-up.
Moderate Mortality Risk — 3–4
Rockall Score 3-4. Moderate mortality risk (5-10%).
Management: Admit for observation. Start IV PPI therapy. Schedule endoscopy within 24 hours. Monitor hemoglobin and vital signs.
High Mortality Risk — 5–6
Rockall Score 5-6. High mortality risk (10-20%).
Management: Urgent endoscopy required (within 12 hours). IV PPI infusion. Consider ICU admission. Type and crossmatch for possible transfusion.
Very High Mortality Risk — 7–11
Rockall Score 7-11. Very high mortality risk (30-60%).
Management: Immediate endoscopy. ICU admission strongly recommended. IV PPI bolus + continuous infusion. Consider endoscopic therapy. Blood transfusion as needed. Surgical or IR consult. Monitor for rebleeding.
Reference Ranges
| Population | Normal Range | Notes |
|---|---|---|
| Patients with upper GI bleeding | 0-11 points (Low: 0-2, Moderate: 3-4, High: 5-6, Very High: 7-11) | Higher score = higher mortality risk. Low: <3%, Moderate: 5-10%, High: 10-20%, Very High: 30-60% mortality. |
Dr. Mahmoud El-Sayed
Dr. Mahmoud is an endocrinology consultant with expertise in metabolic liver disease assessment.
View medical review board & editorial policy →Example Calculation
A 75-year-old man presents with hematemesis and melena. Vital signs: BP 95/60 mmHg, pulse 110 bpm (shock score = 2). He has a history of CAD and CKD (comorbidity score = 3). Age 75 (score = 1). Endoscopy reveals a duodenal ulcer with a visible vessel (diagnosis score = 1, stigmata score = 1). Total Rockall score = 1 + 2 + 3 + 1 + 1 = 8 (Very High risk, 30-60% mortality). This patient requires ICU admission, immediate endoscopic hemostasis, IV PPI therapy, and close monitoring for rebleeding.
Related Conditions
Related Medications
Common Mistakes
Using the full Rockall score without endoscopic findings available
The full Rockall score requires endoscopic variables (diagnosis and stigmata). Use the clinical/admission Rockall score (age, shock, comorbidity only) for initial risk stratification before endoscopy. The clinical score ranges from 0-7.
Applying Rockall score to variceal bleeding without adjustment
The Rockall score was primarily developed and validated for non-variceal upper GI bleeding. In variceal bleeding, use disease-specific scores such as the Child-Pugh score or MELD score for mortality prediction, as Rockall may underestimate risk in this population.
Frequently Asked Questions
What is the difference between the admission Rockall score and the full Rockall score?
How does the Rockall score compare to the Glasgow-Blatchford score?
Can the Rockall score be used in patients with lower GI bleeding?
References
- Rockall TA, Logan RF, Devlin HB, Northfield TC. Risk assessment after acute upper gastrointestinal haemorrhage. Gut. 1996;38(3):316-321. PubMed
- Gralnek IM, Dumonceau JM, Kuipers EJ, et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2015;47(10):a1-46. PubMed
- Laine L, Jensen DM. Management of patients with ulcer bleeding. Am J Gastroenterol. 2012;107(3):345-360. PubMed
- Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet. 2000;356(9238):1318-1321. PubMed